Authors: Jones G, Pardos de la Gandara M, Herrera-Leon L, Herrera-Leon S, Varela Martinez C, Hureaux-Roy R, Abdallah Y, Nisavanh A, Fabre L, Renaudat C, Mossong J, Mattheus W, Huard C, Le Borgne C, de Valk H, Weill FX, Jourdan-Da Silva N
On 18 January 2019, a cluster of four isolates of Salmonella enterica serotype Poona (S. Poona) was identified in infants under 1 year of age. The isolates were received from 20–24 December 2018 at the French National Reference Centre for Escherichia coli, Shigella and Salmonella (NRC-ESS, Institut Pasteur). Initial investigations identified consumption of the same brand of rice-based powdered infant formula (Brand A formula).
On 21 January 2019, the Directorate of the Ministry of Economy in charge of consumers’ affairs (DGCCRF) identified that the Brand A formula had been manufactured at a single production facility in Spain, Facility X. After additional isolates of S. Poona in infants consuming Brand A formula were identified, the French distributer initiated a recall of all Brand A formula manufactured at Facility X on 24 January
Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin